Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management
Case report and review of the literature
It may help reduce the appearance of dullness, dark spots, uneven tone, and dryness when used consistently
It may also appeal to patients who are newer to GLP-1 medications and want a well-established medication pathway before considering a more potent dual-action option
Both: 99%+ purity, third-party verified by Janoshik Analytical, available from Durham Peptides
Fractyl is based in Burlington, MA
US$ 28.76
/product/65/8994952/1.jpg?6054)
US$ 23.41
US$ 25.89
